Society for Neuroscience - Search

Skip Navigation

  • join logo Join
  • hands shaped like a yellow heart icon Give
  • advocate logo Advocate
  • publish logo Publish
  • Icon with thought bubbles Learn
Shop Sign In
SfN Logo 2025
  • Membership
    • Learn About Membership
      • Individual Member Benefits
      • Institutional Program Member Benefits
      • Sustaining Associate Member Benefits
      • Get Involved at SfN
    • Become a Member
      • Sponsorship Information for New Members
      • Membership Categories & Fees
      • Membership Fees for Developing Countries
      • Renew Individual Membership
    • Member Resources
      • Automatic Renewals
      • Frequently Asked Questions
      • Individual Member Directory
      • Member Obituaries and Memorial Donations
    • Learn About Local Chapters
      • Start or Reactivate a Chapter
      • Resources for Chapters
      • Submit Annual Report
      • Chapter Directory
      • Frequently Asked Questions
  • Meetings
    • Meetings Overview
    • Neuroscience 2025
      • Presenter Resources
      • Itinerary Planner and Mobile App
      • Virtual Component
      • Sessions and Events
      • Registration
      • Housing and Travel
      • Exhibits
      • FAQs
    • Global Events
      • SfN Virtual Events
    • Past and Future Annual Meetings
      • Neuroscience 2024
      • Neuroscience 2023
      • Search Past Annual Meeting Abstracts
      • Attendance Statistics
    • Meeting Policies and Guidelines
      • Code of Conduct at SfN Events
      • Growth and Opportunity Strategy
      • Photography & Recording Policy
      • Presenter Guidelines and Policies for SfN Events
    • Meeting Awards
      • Trainee Professional Development Award
      • International Travel Awards
      • FENS Member Awards to SfN Annual Meeting
      • IBRO Member Awards to SfN Annual Meeting
      • JNS Member Awards to SfN Annual Meeting
  • Careers
    • Careers Overview
    • Institutional Program (IP) Directory
    • NeuroJobs Career Center
      • Job Seekers
      • Employers
    • 2025 Graduate School Fair
    • Career Tools and Resources
      • Neuronline
      • Neurobiology of Disease Workshop
      • Responsible Conduct of Research Short Courses
      • Neuroscience Departments and Program Workshop
      • Global Funding Sources
    • Higher Education and Training
      • Core Competencies
      • Neuroscience Training Program Survey
    • Awards
      • Outstanding Career and Research Achievements
      • Early Career
  • Initiatives
    • Initiatives Overview
    • Awards
      • 2025 Award Recipients
      • Awards and Prizes FAQ
      • Trainee Professional Development Award
    • Neuroscience Scholars Program
    • Neuronline
      • Webinars
      • Articles
      • Videos
      • Podcasts
      • Collections
    • Resources to Stay Connected
      • SfN Zoom Backgrounds
    • Community
    • Women and Neuroscience
      • Increasing Women in Neuroscience (IWiN) Courses & Toolkit
      • Celebration of Women in Neuroscience Event
      • Awards
    • Animals in Research
      • Support for Members and Institutions
      • Tools and Resources
      • Resources for Medical Students
    • Public Education Programs
      • Resources for Educators
      • Brain Awareness Video Contest
      • Life of a Neuron Exhibit
  • Advocacy
    • Advocacy Overview
    • Advocacy Response
    • Advocacy Network
      • The NeuroAdvocate Challenge
      • Advocacy Action Center
      • Advocacy Best Practices
      • Advocacy Network News
      • Advocacy Training Seminars
    • US Advocacy Programs
      • Capitol Hill Day
      • Connect with Policymakers
      • Early Career Policy Ambassadors
      • Partner with a Local Chapter
      • Engage the Media
    • Global Advocacy Programs
      • Global Neuroscience Initiatives
      • Global Funding
      • North American Programs
    • Science Funding
      • Advocacy Videos
      • Advocacy Resources
      • US Neuroscience Initiatives
      • Funding Priorities and Processes
    • Policy Positions
      • Statements and Testimony
      • Sign-On Letters
  • Outreach
    • Outreach Overview
    • BrainFacts.org
    • Find a Neuroscientist
    • Brain Awareness Campaign
      • Webinar: The ABC's of BAW
      • How to Get Involved
    • Awards
      • Award for Education in Neuroscience
      • Next Generation Award
      • Chapter of the Year Award
      • Science Educator Award
  • Publications
    • Publications Overview
    • SfN News
    • JNeurosci
    • eNeuro
    • SfN Nexus
    • Neuroscience Quarterly
    • Annual Report
    • History of Neuroscience Autobiographical Chapters
  • About
    • About Overview
    • Mission and Strategic Plan
    • What We Do
      • Annual Report
      • Bylaws
      • Resolutions to the Bylaws
      • Environmental Commitment
      • Strategic Partners
      • History of SfN
    • SfN 50th Anniversary Celebration
    • NIH Public Health Service-Supported Funding Financial Conflict of Interest Policy
    • Volunteer
      • SfN Council
      • SfN Presidents
      • Committees
      • Elections
      • Call for Nominations
    • Professional Conduct
      • SfN Ethics Policy
      • Guidelines for Responsible Conduct Regarding Scientific Communication
      • Code of Conduct at SfN Events
      • Commitment to Scientific Integrity
      • Neuronline Digital Learning Community Guidelines
    • History of Neuroscience
      • Autobiographical Chapters
      • Autobiographical Videos of Prominent Neuroscientists
      • Classic Papers
      • Neuroscience History Resources
      • Robert Doty's Chapter on Neuroscience
    • Careers and Staff
      • Staff List
  1. Search

Filter

  • (2)
  • (1)
  • (3)
  • (6)
  • (8)
  • (1)
  • (574)
  • (3)
  • (2)
  • (8)
Filter
341 - 350 of 892 results
  • Abstract
    Prenatal delta 9 tetrahydrocannabinol exposure elicits divergent age and sex dependent cognitive impairments and dysregulation of prelimbic neural activity via disruption of hippocampal molecular signaling cascades and fatty acid synthesis
    The mammalian hippocampus is a chief neural region involved in cognition and memory formation, and a principal structure mediating the neuropsychiatric side effects of cannabinoid exposure. Despite evidence that cannabis use during pregnancy can precipi...
    Oct 20, 2019
  • Abstract
    Limbic dopamine and opioid impairment in the prenatal cannabis-exposed human fetus.
    Marijuana (Cannabis sativa) is one of the most used illicit drugs in our society. Impairment in brain functions and behavioral problems have been documented in children exposed to marijuana during prenatal development. The active component of marijuana, D9-tetrahydrocannabinol acts through cannabinoid receptor in the brain which tightly interacts with the mesocorticolimbic dopamine and endogenous opioid system. We have previously identified reduced dopamine D2 receptor mRNA expression in amygdala of prenatal cannabis-exposed human fetuses. The present study investigated the effects of in utero cannabis exposure on D2 expression levels in nucleus accumbens (NAc) and opioid-related genes in the human fetal forebrain. The study group consisted of midgestational fetuses from saline-induced voluntary abortion. The effect of prenatal cannabis exposure was analyzed by multiple regression controlling for confounding variables (maternal alcohol and cigarette use, fetal age, sex, postmortem interval and fetal growth...
    Nov 14, 2005
  • Abstract
    Characterization of distinct neuropsychiatric trajectories in FTLD-tauopathies
    Introduction: Frontotemporal lobar degeneration (FTLD) is a neurodegenerative disease commonly caused by 3R (Pick’s disease, “PiD”) or 4R tauopathies (corticobasal degeneration, “CBD” and progressive supranuclear palsy, “PSP”). FTLD-tauopathies can lead...
    Nov 11, 2021
  • Abstract
    Effect of cannabis on motor and non - motor symptoms of Parkinson’s disease: a behavioral and pharmacological study
    Interest in cannabis and cannabinoid research for treatment of neurological disorders have received growing attention over the past years. Although there is evidence from animal and human studies that cannabis has some symptomatic effects, many therapeu...
    Nov 11, 2021
  • Abstract
    Molecular determinants of Ca2+- and calmodulin-dependent regulation of CaV2.1.
    In the nervous system, Ca2+-dependent facilitation and inactivation (CDF and CDI) of Cav2.1 channels may fine-tune presynaptic Ca2+ concentrations and contribute to activity-dependent synaptic plasticity. The mechanism for this dual feedback regulation by Ca2+ may involve calmodulin (CaM) binding directly to two sites, a CaM-binding domain (CBD) and an IQ-like domain in the C-terminal portion of the Cav2.1 α1 subunit (α12.1). In this study, we describe the molecular determinants for Ca2+-dependent modulation of Cav2.1, which reside both in CaM itself and in the CBD and IQ-like domain of α12.1. In transfected tsA-201 cells, CDI but not CDF was largely reduced in channels lacking the CBD. By contrast, alanine substitution of the first two residues of the IQ-like domain (IQ-AA) prevented CDF but not CDI. Moreover, Cav2.1 channels lacking the CBD and containing the IQ-AA mutations were deficient in both CDI and CDF. Ca2+ binding to CaM was critical for CDI and CDF, which were both nearly abolished by inactivat...
    Nov 12, 2003
  • Functional Tolerance and Blockade of Long-Term Depression at Synapses in the Nucleus Accumbens after Chronic Cannabinoid Exposure | Journal of Neuroscience
    The rewarding properties of the psychoactive constituents of marijuana, termed “cannabinoids,” may reflect actions on synaptic transmission in the nucleus accumbens (NAc). Furthermore, long-term changes in these synapses may support the addictive process. Excitatory and inhibitory synapses are acutely inhibited by cannabinoids in the NAc, and endogenous cannabinoids (endocannabinoids) play a critical role in the expression of long-term depression (LTD) of excitatory cortical afferents in this structure. Because humans often use marijuana for prolonged periods, we examined the impact of long-term cannabinoid exposure on synaptic processes in an animal model. Electrophysiological recordings in rat brain slices containing the NAc were performed after chronic exposure to vehicle solution, Δ9-tetrahydrocannabinol (THC), or the cannabinoid agonist R (+)-[2,3-dihydro-5-methyl-3-[(morpholinyl)methyl]pyrrolo[1,2,3-de]-1,4-benzoxazin-6-yl]-(1-naphthalenyl)methanone mesylate (WIN55,212-2). Extracellular glutamatergic...
    Jun 15, 2003 Alexander F. Hoffman
  • Abstract
    Perinatal omega-3 fatty acid supplementation rescues the aberrant cognitive and affective symptomology in a prenatal cannabis exposure model of schizophrenia
    Clinical and preclinical studies indicate prenatal cannabis exposure (PCE) pathologically effects fetal brain development and may increase vulnerability to neuropsychiatric disorders, including schizophrenia, cognitive and mood/anxiety disorders. Howeve...
    Nov 11, 2021
  • Abstract
    Tau-immunoreactive thorn-shaped astrocytes in brain neurodegeneration and aging
    Aggregated microtubule associated protein tau in neurofibrillary tangles is a pathological hallmark of Alzheimer’s disease (AD). In other tauopathies, such as corticobasal degeneration (CBD) and progressive supranuclear palsy (PSP), astrocytic tau inclu...
    Nov 11, 2021
  • Abstract
    Leptin regulates endocannabinoid signaling in an appetite-related neural circuit.
    Delta9(-)-tetrahydrocannabinol (THC) in marijuana as well as anandamide, an endogenous ligand for cannabinoid receptors, increases food intake and body weight (Cota et al., 2003a; Hao et al., 2000; Williams and Kirkham, 2002). Prior studies suggest that endogenous cannabinoids and their receptors are present in the lateral hypothalamic area (Cota et al., 2003b; Moldrich and Wenger, 2000). In addition, immunohistochemical and in situ hybridization studies demonstrated that leptin receptors are found within the LH (Elmquist et al., 1998; Hakansson et al., 1998). We examined the mechanism by which THC may stimulate appetite in studies of synaptic transmission within the LH. We examined endocannabinoid signaling and tested for effect of leptin on endocannabinoid signaling by comparing synapses in wild-type (+/+) lateral hypothalamic slices with slices obtained from leptin deficient (ob/ob) mice. Brief depolarization of postsynaptic neurons depressed GABAergic transmission in all mice independent of genotype. L...
    Oct 23, 2004
  • Abstract
    ULTRASTRUCTURAL ANALYSIS OF THE CANNABINOID RECEPTOR (CB1) IN THE RAT NORADRENERGIC LOCUS COERULEUS (LC) IN RAT BRAIN.
    Several lines of evidence suggest direct actions of delta 9-tetrahydrocannabinol (THC), the main psychoactive constituent of Cannabis sativa, in modulating brain noradrenergic neurons. Noradrenergic neurons have been shown to play an important role in the manifestation of catalepsy induced by THC (Kataoka et al., Neuropharm. 26:55-60, 1987). In addition, cannabinoids activate descending noradrenergic neurons resulting in antinociception via the stimulation of spinal alpha 2-adrenoceptors (Lichtman and Martin, Brain Res. 559:309-314, 1991). Finally, exposure of pregnant rats to THC affects the gene expression and activity of tyrosine hydroxylase (TH) in the brains of their offspring (Bonnin et al., J Mol Neurosci, 7:291-308, 1996). In the present study, we examined the ultrastructural distribution of CB1 using immunoperoxidase or immunogold-silver labeling in the LC of adult male Sprague Dawley rats. Subsequently, we combined immunocytochemical detection of an antibody directed against the CB1 receptor and ...
    Nov 13, 2001
  • Previous
  • 33
  • 34
  • 35
  • 36
  • 37
  • Next

Featured

  • SfN Selects Kevin B. Marvel, PhD, as Next Executive Director
  • Read the Neuroscience Quarterly - Fall 2025
  • Renew your SfN Membership Today!
SfN Websites
  • BrainFacts.org logo
  • eNeuro logo
  • JNeurosci logo
  • Neuronline logo
Engage with SfN
  • join Join
  • give Give
  • advocate Advocate
  • publish Publish
Quick Links
  • SfN News
  • For Press
  • Global Events
  • Contact Us
  • Advertise
  • Code of Conduct
  • Jobs at SfN
  • SfN Store
  • Social Media
Follow SfN
  • BlueSky logo
  • Facebook logo
  • Instagram logo
  • LinkedIn logo

  • Threads logo
  • X Logo
  • YouTube logo
SfN logo with "SfN" in a blue box next to Society for Neuroscience in red text and the SfN tag line that reads "Advancing the understanding of the brain and nervous system"
1121 14th Street NW, Suite 1010, Washington, D.C. 20005
(202) 962-4000 | 1-888-985-9246
  • Accessibility Policy
  • Disclaimer
  • Privacy Notice
  • Contact Us

Copyright ©
Society for Neuroscience